Vol 8, No 5 (October 01, 2019) - Hepatobiliary Surgery and Nutrition

Original Article

Endogenously increased n-3 PUFA levels in fat-1 transgenic mice do not protect from non-alcoholic steatohepatitis

Marie Liebig, Dirk Dannenberger, Brigitte Vollmar, Kerstin Abshagen

PDF Pages: 447-458 Full Text (2214) Open Access

Bilateral proficiency over time leads to reduced donor morbidity in living donor hepatectomy

Viola Huang, Chao-Long Chen, Yu-Hung Lin, Tsan-Shiun Lin, Chih-Che Lin, Shih-Ho Wang, Chee-Chien Yong, Chih-Yi Chen, Yu-Fan Cheng

PDF Pages: 459-469 Full Text (1721) Open Access

Perioperative characteristics and management of liver transplantation for isolated methylmalonic acidemia—the largest experience in China

Yi-Zhou Jiang, Li-Ying Sun, Zhi-Jun Zhu, Lin Wei, Wei Qu, Zhi-Gui Zeng, Ying Liu, Yu-Le Tan, En-Hui He, Rui-Fang Xu, Liang Zhang, Jun Wang, Xiao-Jie Chen

PDF Pages: 470-479 Full Text (2395) Open Access

Development and validation of a nomogram for survival benefit of lymphadenectomy in resected gallbladder cancer

Mingyu Chen, Jian Lin, Jiasheng Cao, Hepan Zhu, Bin Zhang, Angela Wu, Xiujun Cai

PDF Pages: 480-489 Full Text (1935) Open Access

Review Article

Machine perfusion strategies in liver transplantation

Andrea Schlegel, Xavier Muller, Philipp Dutkowski

PDF Pages: 490-501 Full Text (3669) Open Access

Editorial

The future of organ-oriented research and treatment

Qiang Zhao, Yu Nie, Zhiyong Guo, Xiaoshun He

PDF Pages: 502-505 Full Text (1892) Open Access

Increasing contribution of non-alcoholic fatty liver disease to hepatocellular carcinoma incidence and mortality in U.S. Medicare

Carrie R. Wong, Joseph K. Lim

PDF Pages: 506-508 Full Text (1206) Open Access

Relative skeletal muscle mass and non-alcoholic fatty liver disease: from association to causation

Hee Yeon Kim, Jong Young Choi, Yong-Moon Park

PDF Pages: 509-511 Full Text (1759) Open Access

Chasing the right path: tips, tricks and challenges of robotic approach to posterior segments

Fabrizio Di Benedetto, Giuseppe Tarantino, Paolo Magistri

PDF Pages: 512-514 Full Text (1190) Open Access

Ramucirumab as a second-line treatment for hepatocellular carcinoma: reaching out further to patients with elevated alpha-fetoprotein

Edoardo G. Giannini, Franco Trevisani

PDF Pages: 515-518 Full Text (1306) Open Access

Multiple hepatocellular carcinomas: liver resection or transcatheter arterial chemoembolization?

Yin Lei, Lau Wan Yee, Wei-Ping Zhou

PDF Pages: 519-521 Full Text (1196) Open Access

Overview of emerging treatment of non-alcoholic fatty liver disease: more than one drug needed?

Dong Yun Kim, Jun Yong Park

PDF Pages: 522-524 Full Text (1870) Open Access

The effect of direct-acting antivirals on hepatocellular carcinoma recurrence: still waiting for the turning point

Gaetano Serviddio, Rosanna Villani

PDF Pages: 525-526 Full Text (1070) Open Access

Potential therapeutic strategies to target gut microbiota in hepatocellular carcinoma

Amedeo Amedei

PDF Pages: 527-529 Full Text (1638) Open Access

Liver resection for multifocal hepatocellular carcinoma: is it an option?

Luca Viganò, Guido Costa, Luca Di Tommaso

PDF Pages: 530-533 Full Text (1514) Open Access

Behavioral healthy nutrition and physical activity counseling in cardiovascular disease prevention: where we are now?

Demosthenes B. Panagiotakos, Matina Kouvari

PDF Pages: 534-536 Full Text (1239) Open Access

Commentary

Biliary spillage a new prognostic factor in gallbladder cancer?

Xabier de Aretxabala

PDF Pages: 537-538 Full Text (1555) Open Access

Viewpoint

Big size is not all, even better!

Roberto Ivan Troisi, Mariano Cesare Giglio, Roberto Montalti

PDF Pages: 539-540 Full Text (1236) Open Access

Striving for decreased post-transplant hepatocellular carcinoma recurrence without excluding potentially curable patients: the utility of tumor biology

Russell Evan Rosenblatt, Karim Jarir Halazun

PDF Pages: 541-542 Full Text (1153) Open Access

Liver resection versus chemoembolization for patients with multifocal hepatocellular carcinoma

Victor M. Zaydfudim, Reid B. Adams

PDF Pages: 543-545 Full Text (1415) Open Access

Is there a place for Ramucirumab after Sorafenib in patients with advanced HCC?

Yeo Jeong So, Sophia Frentzas, Eva Segelov

PDF Pages: 546-548 Full Text (1217) Open Access

Viewpoint: necroptosis influences the type of liver cancer via changes of hepatic microenvironment

Waqar K. Saeed, Dae Won Jun

PDF Pages: 549-551 Full Text (1388) Open Access

The current role of liver surgery in the treatment of colorectal liver metastases

Stefan Heinrich

PDF Pages: 552-554 Full Text (1021) Open Access

What’s the next step in evaluating laparoscopic pancreaticoduodenectomy?

Fernando Burdío, Luís Grande, Ignasi Poves

PDF Pages: 555-556 Full Text (1110) Open Access

Radial margin status should be determined in resected perihilar cholangiocarcinoma

Roeland F. de Wilde, Bas Groot Koerkamp

PDF Pages: 557-559 Full Text (1583) Open Access

Sarcopenic obesity in liver cancer: it is SO complicated

Gyorgy Baffy

PDF Pages: 560-562 Full Text (1434) Open Access

Letter to the Editor

Is direct acting antiviral therapy for hepatitis c viral infection associated with increased risk of hepatocellular carcinoma before or after liver transplantation?

Ashokkumar Jain, Danielle Miller, Zakiyah Kadry

PDF Pages: 563-565 Full Text (1559) Open Access

Early allograft dysfunction after liver transplantation with donation after cardiac death donors

Junbin Zhou, Qiang Wei, Shusen Zheng, Xiao Xu

PDF Pages: 566-568 Full Text (2552) Open Access

Heterogenous responses to nivolumab in a single metastatic nodule in hepatocellular carcinoma: role of salvage surgery

Hyun Yang, Pil Soo Sung, Jaejun Lee, Seung Kew Yoon, Eun Sun Jung, Cheon-Soo Park, Si Hyun Bae

PDF Pages: 569-571 Full Text (1352) Open Access